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Philadelphia, PennsylvaniaABSTRACT While the importance of viral fusion peptides (e.g., hemagglutinin (HA) and gp41) in virus-cell membrane fusion is
established, it is unclear how these peptides enhance membrane fusion, especially at low peptide/lipid ratios for which
the peptides are not lytic. We assayed wild-type HA fusion peptide and two mutants, G1E and G13L, for their effects on the
bilayer structure of 1,2-dioleoyl-3-sn-phosphatidylcholine/1,2-dioleoyl-3-sn-phosphatidylethanolamine/Sphingomyelin/Choles-
terol (35:30:15:20) membranes, their structures in the lipid bilayer, and their effects on membrane fusion. All peptides bound
to highly curved vesicles, but fusion was triggered only in the presence of poly(ethylene glycol). At low (1:200) peptide/lipid
ratios, wild-type peptide enhanced remarkably the extent of content mixing and leakage along with the rate constants for these
processes, and significantly enhanced the bilayer interior packing and filled the membrane free volume. The mutants caused no
change in contents mixing or interior packing. Circular dichroism, polarized-attenuated total-internal-reflection Fourier-transform
infrared spectroscopy measurements, and membrane perturbation measurements all conform to the inverted-V model for the
structure of wild-type HA peptide. Similar measurements suggest that the G13L mutant adopts a less helical conformation in
which the N-terminus moves closer to the bilayer interface, thus disrupting the V-structure. The G1E peptide barely perturbs
the bilayer and may locate slightly above the interface. Fusion measurements suggest that the wild-type peptide promotes
conversion of the stalk to an expanded trans-membrane contact intermediate through its ability to occupy hydrophobic space
in a trans-membrane contact structure. While wild-type peptide increases the rate of initial intermediate and final pore formation,
our results do not speak to the mechanisms for these effects, but they do leave open the possibility that it stabilizes the transition
states for these events.INTRODUCTIONMembrane fusion occurs in all life processes inwhich cellular
contents must be passed through a membrane barrier, such as
viral infection, neurotransmission, fertilization, and intracel-
lular protein trafficking. Infection by enveloped viruses
involves fusion of viral and cellular membranes with sub-
sequent transfer of viral genetic material into the cell. The
virus components that mediate fusion are glycoproteins and
the best-characterized such glycoprotein is influenza virus
hemagglutinin (HA) (1,2). HA is a trimer of identical
subunits, each of which is comprised of two glycopeptides
linked by a single disulfide bond, with one glycopeptide
accomplishing receptor binding (HA1, 328-residue) and the
other working as a fusion machine (HA2, 221-residue) (3).
A highly conserved 20-amino-acid amphipathic peptide at
the N-terminus of HA2 is essential for fusion activity and is
termed the ‘‘fusion peptide’’ (4). Fusion peptides of influenzaSubmitted March 21, 2011, and accepted for publication July 8, 2011.
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0006-3495/11/09/1095/10 $2.00virus strain X-31 (HA X-31) and HIV (gp41) cannot induce
membrane fusion but do promote aggregation and rupture
at high peptide/lipid ratios (P/Ls). However, fusion peptides
promote fusion between vesicles brought into close apposi-
tion by poly(ethylene glycol) (PEG) (5).
Structural studies of the 20-residue HA fusion peptide
have been of necessity low resolution, as the peptides
have limited solubility and trigger membrane disruption at
high P/Ls. One common model based on infrared spectro-
scopic experiments envisions a fully helical peptide with
its N-terminus inserted into the bilayer at an angle of
roughly 54 to the bilayer-normal (6). A detailed model
derives from NMR studies of fusion peptide joined at its
C-terminus to a charged carrier peptide that was designed
to allow fusion peptide to be solubilized in dodecyl phos-
phocholine (DPC) micelles. By combining NMR data
with electron spin resonance experiments on spin-labeled
carrier-stabilized peptide associated with membranes, the
peptide was proposed to adopt an inverted-V structure (7).
Oriented Fourier transform infrared (FTIR) experiments
along with membrane perturbation and fluorescence data
obtained with the unmodified peptide at lower concentra-
tions are consistent with the inverted-V model with both
the C- and N-termini protruding somewhat into the bilayer
but with polar residues near the middle of the peptide in
the interfacial region of the bilayer (8).doi: 10.1016/j.bpj.2011.07.031
1096 Haque et al.NMR studies of a slightly longer (23 residues including
the natural sequence, WTG at the C-terminus) peptide asso-
ciated with DPC micelles suggest a helical hairpin structure
with polar residues arranged on one face of the pair and the
two tryptophans and nonpolar residues on the other (9).
While this model would be consistent with FTIR data
showing an orientation roughly parallel with a membrane
surface (8), it should result in considerable perturbation of
interfacial packing and little perturbation of core bilayer
order—the opposite of what is observed with the 20-residue
peptide (8). For this reason, we view the inverted-V model
(an incompletely folded helical hairpin) as the best approx-
imation for the structure of the 20-residue peptide examined
here.
It remains to be seen how the HA fusion peptide (or any
fusion peptide) functions to promote fusion in vivo. Based
on studies of lamellar-to-nonlamellar phase transitions
(particularly, lamellar to hexagonal) in lipid suspensions,
some have proposed that fusion peptides might impose a
negative curvature that is inconsistent with the intrinsic
curvature of juxtaposed lamellar structures and thus pro-
mote formation of curved nonlamellar fusion intermediates
(10,11). Of course, the stability of lamellar lipid phase rela-
tive to nonlamellar phases is influenced by factors other than
intrinsic curvature, such as bending modulus (12), interstice
or void energy (13,14), and Gaussian energy (15). Based on
the influence of both the HA and HIV gp41 fusion peptides
on bilayer structure (8) as well as on the mutual influence
of hexadecane and fusion peptides on fusion, it has been
suggested that fusion peptides might promote fusion by
lowering void energy (5,16). One way to address these
different possibilities is to compare the membrane-perturb-
ing and fusion-promoting influences of wild-type fusion
peptides with those of mutant peptides that fail to support
fusion and/or lytic activity.
Factors that affect lamellar-to-nonlamellar phase equi-
libria may influence the free energies of semistable interme-
diates on the path to fusion (e.g., stalk) but may also
influence the rates at which transitions occur between these
states. To examine this possibility, one needs a mechanistic
model within which to interpret fusion kinetics. We have
previously proposed such a model and have shown it to
account for multiple observations (17). Here we report the
kinetics of PEG-mediated fusion of vesicles composed of
an optimal fusogenic mix of lipids in the presence and
absence of wild-type and two mutant forms, G1E and
G13L, of HA fusion peptide. A G1E mutant peptide from
influenza virus A/Japan/305/57 has reduced efficacy for
fusion in a cell-based assay (4), while a G13L mutant fusion
peptide from the A/PR/8/34 virus strain was impaired in
lysis of model membranes (18). We also compare to wild-
type peptide the structures of these membrane-bound
mutant peptides as well as their influence on bilayer struc-
ture. From these results, we identify at what stage(s) of
the fusion process, and in what ways, the wild-type influ-Biophysical Journal 101(5) 1095–1104enza X-31 HA fusion peptide exerts its unique fusion-
promoting influence.
Finally, by comparing these results with the effects of
these peptides on lipid phase behavior (B. G. Tenchov, D.
P. Siegel, R. C. MacDonald, and B. R. Lentz, unpublished),
we hope to gauge the following:
Does the HA fusion peptide influence fusion by affecting
the curvature energy, the void energy, or some combination
of both? Or does it influence fusion by some other contribu-
tion to the free energy of lamellar or nonlamellar lipid struc-
tures, or perhaps by the transitions between these structures?EXPERIMENTAL PROCEDURES
Materials
Chloroform stock solutions of 1,2-dioleoyl-3-sn-phosphatidylcholine
(DOPC), 1,2-dioleoyl-3-sn-phosphatidylethanolamine (DOPE), bovine
sphingomyelin (SM), and 1-palmitoyl-2-n-(4-nitrobenzo-2-oxa-1,3-diaz-
ole) aminohexanoyl phosphatidylcholine (C6NBDPC) were purchased
from Avanti Polar Lipids (Birmingham, AL) and used without further puri-
fication. The concentration of the stock lipids was determined by phosphate
assay. Cholesterol was purchased from Avanti Polar Lipids and was further
purified by published procedures (20). 1,6-diphenyl-1,3,5-hexatriene (DPH)
and 1-(4-trimethylammonium)-6-diphenyl-1,3,5-hexatriene (TMA-DPH)
were purchased from Molecular Probes (Eugene, OR). 2-(n-Morpholino)
ethanesulfonic acid sodium salt was purchased from Sigma Chemical
(St. Louis, MO). All other reagents were of the highest purity available.
Poly(ethylene glycol) of molecular weight 7000–9000 (PEG 8000) was
purchased from Thermo Fisher Scientific (Waltham, MA) and purified as
previously reported (21).Fusion model and data analysis
Fusion is widely (but not universally) viewed in terms of a multistep process
that proceeds through semistable transient intermediates (14). We have
treated the kinetics of the process in terms of a sequential, two-intermediate
(four-state) model that relates observable events associated with PEG-medi-
ated fusion (lipid mixing, contents mixing, leakage, light scattering, and
pyrene cholesterol fluorescence) to rate constants for evolution of fusion
intermediates and probabilities of events occurring in each state. For all
the systems considered here, lipid mixing, content mixing, and content
leakage data were sufficient to determine the three rate constants and other
parameters (17).
This model is summarized in the following Scheme:
SCHEME 1
Here nV represents n separate vesicles, A is a state with vesicles in contact
within aggregates, I1 and I2 are the intermediate states (stalk and extended
trans-membrane contact (TMC) (22)), and FP is the final fusion pore state.
Each state is characterized by the probability of observing fusion events
(i.e., content mixing {ai}, lipid mixing {bi}, and leakage rate (li}) and
by rate constants (k1, k2, and k3) for interconversion of states. The A-state
HA Fusion Peptide Mutants, PEG-Mediated Fusion 1097is achieved using PEG to aggregate vesicles into molecular contact (23).
The aggregation rate was approximately fivefold greater than k1 and inde-
pendent of the presence of peptide. Step 1 can be reversed if aggregation is
reversed by removing PEG, but is irreversible when aggregation is main-
tained (24), which it is in our experiments.
The sequential, two-intermediate model has 15 parameters: 3 rate
constants and 12 values that describe the probabilities of lipid mixing,
content mixing, and rates of leakage in each state. Four of these probabil-
ities can be set to zero by observation (a0 ¼ 0, b0 ¼ 0, b3 z 0, l3 ¼ 0),
and two normalization conditions (a1 þ a2 þ a3 ¼ 1 and b1 þ b2 ¼1)
constrain another two, leaving nine parameters (three rate constants, three
leakage rate constants, two ai and bi) to be set by comparison to experiment.
Each data set (lipid mixing, content leakage, content leakage) is normally
a double exponential described by four parameters. Global or simultaneous
fitting of all three data sets can thus define 9–12 parameters so that the
parameters should, in theory, not be underdetermined. In practice, we
have found this to be true in that
1. Fitting with different sets of starting parameters always returns the same
final set, and
2. Separate analyses of triplicate experiments yields the same parameters
within parameter uncertainties determined by fitting the individual
data sets or a combined data set.
In addition, we showed (17) that rate constants obtained as described here
from lipid mixing, content mixing, and content leakage data also accounted
for the time dependence of two additional observables related to membrane
structural changes, light scattering, and pyrene cholesterol fluorescence
(25). All this demonstrates that our kinetic model provides a robust descrip-
tion of our data that yields well-defined rate constants that are capable of
accounting for additional observations.
The process of fitting three data sets simultaneously while adjusting nine
model parameters is a daunting task. To facilitate this, we broke the task
down into a series of steps in which a limited number of parameters were
determined at each step using SigmaPlot (Systat Software, San Jose, CA):
Step 1. The lipid-mixing time course (LM(t)) was fit to obtain the rates k1
and k2, the lipid mixing probabilities b1 and b2 ¼ (1b1), and the
total fraction of lipid mixing at long time, fLM.
Step 2. Using k1, k2, and b1 from Step 1, the raw fluorescence data for
leakage and content mixing time courses were fitted globally to
obtain k3, l0, l1, l2, a1, and a2. The long-time total fraction of
content mixing, fCM, is obtained from the parameters derived in
this fit.
Step 3. The fluorescence data were then simulated using these parameters
to obtain plots of observed and predicted fluorescence time courses.
Residual plots obtained from these time courses were examined to
test for systematic fitting errors.
Our kinetic model is based on a structural model of fusion involving a
series of semistable intermediates (modified-stalk model (22) for which
there is considerable evidence (26,27)). This structural model posits that
mixing of trapped contents will occur only in the final FP state, but we
must account for the experimental reality that every system we have exam-
ined showed evidence of contents mixing before final pore formation. We
argue that the structural model is consistent with this observation only
if we allow (17,24) that content mixing occurs with finite probabilities
(a-values) in semistable structural intermediates via fluctuations in their
already stressed structures (17). The existence of transitory or flickering
small pores is widely described for electrophysiological measurements of
fusion events in patch-clamped cells (e.g., see Alvarez de Toledo et al.
(28)) and has been noted even in model membranes (29). In addition, we
clearly observed, using extremely nonleaky small unilamellar vesicles
(SUVs) composed of an 85:15 mixture of dioleoyl-phosphatidylcholine
and dilinoleoyl-phosphatidylcholine two classes of pores,
1. Small and reversible pores that passed protons in the hemifused state
(here I1 and I2) and2. Larger and irreversible pores that passed much larger solutes (DPX and
ANTS) and appear only late in the fusion process (24).
Thus, it is quite clear that contents can mix between compartments both
early and late in the fusion process, although the natures of the structures
that allow these two processes are likely quite different.RESULTS
Binding of HA wild-type and mutant peptides
to PC/PE/SM/CH (35/30/15/20) SUV
We have already reported binding of HA wild-type peptide
to DOPC and phosphatidylcholine (PC)/ phosphatidyletha-
nolamine (PE)/Sphingomyelin (SM)/Cholesterol (CH) SUV
as observed by
1. Monitoring tryptophan fluorescence intensity changes
after addition of vesicles, and
2. Monitoring fluorescence intensity of membrane-bound
DPH as a result of energy transfer from bound peptide
(5,8).
Binding constants by bothmethods were consistent.We used
the former method here to determine the binding constants of
wild-type HA, G1E, and G13L peptides. We performed the
experiments at two different concentrations of the peptide,
and data were fitted globally to a standard surface-binding
model (30). The binding parameters (Kd in mM and N (lipids
per bound peptide)) for the three peptides are: 0.515 0.06,
285 5; 0.675 0.05, 215 5; and 0.895 0.07, 125 4 for
the wild-type, G1E, and G13L peptides, respectively, where
the error in Kd is the standard deviation derived from global
fitting of binding data obtained at two different peptide
concentrations. We conclude that the wild-type peptide
bound more tightly and occupied more membrane surface
than either the G13L or G1E mutant, with the latter occu-
pying remarkably little membrane surface.Effect of HA wild-type and mutant peptides
on vesicles in the absence of PEG
We reported previously single-time-point observations of
wild-type (X-31 strain) fusion peptide-induced content
leakage and lipid mixing but not content mixing between
DOPC SUVs in a peptide-concentration-dependent fashion
(20). Here we report in Fig. 1 the initial rates of lipid mixing
and leakage of DOPC/DOPE/SM/CH (35:30:15:20) SUVs
plotted for different lipid/peptide ratios (L/Ps) for wild-
type and mutant peptides in the absence of PEG at 37C.
While all three fusion peptides significantly increased the
rates of content leakage at high peptide/lipid ratios (P/Ls),
none of them induced any mixing of contents between
SUVs in the absence of PEG. Wild-type peptide triggered
some lipid mixing between SUVs at all P/Ls, as shown in
Fig. 1. Data obtained at a P/L of 1:200 were also fit to a
double exponential to obtain an exponential constant com-
parable to values obtained in the presence of PEG.Biophysical Journal 101(5) 1095–1104
FIGURE 1 Effect of HAwild-type and mutant peptides on (A) lipid mix-
ing and (B) leakage in PC/PE/SM/CH (35/30/15/20) SUVs in the presence
of wild-type fusion peptide (solid triangle), G13L (open circle) peptide, and
G1E (solid squares) peptide, in the absence of PEG. Measurements were
carried out in 10 mM 2-(n-morpholino)ethanesulfonic acid (MES),
100 mM NaCl, 1 mM CaCl2, 1 mM ethylenediaminetetraacetic acid
(EDTA), pH 5.0 at 37C. Total lipid concentration was 0.2 mM. Values pre-
sented here are the average from three experiments such as shown in Fig. 2.
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1098 Haque et al.Because rapid lipid exchange requires close approach of
membranes (31), it is not surprising that the k1 values
obtained in the absence of PEG (10, 4, and 2  104 s1
for wild-type, G13L, and G1E peptides, respectively) were
an order-of-magnitude slower than seen in the presence of
PEG (Table 1). However, the order of these rates was
approximately the same in the presence and absence of
PEG (WT > G13L ~ G1E). Both G13L and G1E triggered
almost imperceptible lipid exchange between vesicles at
low P/Ls (indeed, G1E seems totally ineffective), but
produced some lipid mixing above P/L ¼ 1:100. Wild-
type and G13L peptides produced significant leakage at
all P/Ls, but, consistent with a previous report (18), wild-
type was more effective. Again, the G1E peptide was less
effective than wild-type or G13L in triggering leakage.T
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on PEG-mediated SUV fusion
We showed in an earlier publication that PEG had no
influence on wild-type gp41 peptide Trp fluorescence
intensity, membrane binding, and depth of penetration into
membranes (16). As controls, we showed insensitivity of
Trp fluorescence and binding of wild-type HA fusion
peptide and its G1E and G13L mutants to membranes wasBiophysical Journal 101(5) 1095–1104
HA Fusion Peptide Mutants, PEG-Mediated Fusion 1099independent of the presence of PEG (data not shown),
confirming that the low concentration of PEG used in our
experiments is unlikely to affect either formation of the
peptide-membrane complex or the physical state of the
peptide in solution.
Fig. 2 shows time courses of PEG-mediated lipid mixing
(LM) (Fig. 2 A), contents mixing (CM) (Fig. 2 B), and
content leakage in DOPC/DOPE/SM/CH SUVs (Fig. 2 C)
in the presence of wild-type and mutant peptides (L/P ¼
200:1) at 5% PEG at 26C. All three data sets (LM, CM,
and leakage) were fitted globally to the model in Scheme 1
to obtain the rate constants of each step and probabilities of
lipid mixing and content mixing in each intermediate state
(17). Wild-type peptide increased by 40% the total extent
of contents mixing, doubled the rate of initial intermediate
formation, increased by somewhat less the k2 and k3 rateFIGURE 2 Effect of HAwild-type (2), G1E (3), and G13L (4) peptides,
compared to the absence of peptide, i.e., control (1), on kinetics of (A)
lipid mixing, (B) contents mixing, and (C) leakage in PC/PE/SM/CH
(35:30:15:20 mol %) SUVs in the presence of 5% PEG at 26C. Results
(observed fluorescence intensity changes) are shown for an L/P of 200:1.
Measurements were carried out in 10 mM MES, 100 mM NaCl, 1 mM
CaCl2, 1 mM EDTA, pH 5.0 at a total lipid concentration was 0.2 mM.
Smooth curves drawn through the data show a two-state sequential model
global fit. The fitting parameters shown in Table 1 were obtained by
combining data taken on three different samples on different days.constants (~30 and 50%, respectively), and increased the
probability that content mixing and lipid mixing occur in
state I1 at the expense of content mixing in I2 (Table 1).
The two mutant peptides produced none of these effects
and may have slightly decreased the extent of content
mixing. Finally, of the three peptides, only the wild-type
significantly increased the rate of content leakage.Effect of HA wild-type and mutant peptides
on bilayer properties
We examined the bilayer properties of membranes using
three different fluorescent probes, C6NBDPC, DPH, and
TMA-DPH, to characterize membrane structural properties.
DPH reports order in the interior of the lipid bilayer. TMA-
DPH locates to the interfacial region (32) and probes
order and/or thermal motions in this region (33). C6NBDPC
partitions between the upper region of the bilayer (34) and
micelles (34) with its average lifetime reflecting the par-
tition coefficient between these two phases (33), making
C6NBDPC a sensitive reporter of free volume and lipid
packing within membrane outer leaflets (33,35). We mea-
sured the phase shifts and modulation ratios of frequency-
modulated C6NBDPC fluorescence at different P/Ls in
DOPC/DOPE/SM/CH SUVs and analyzed these data in
terms of three lifetime components to obtain the mole frac-
tions of probe in both environments (33). The changes in
the average lifetime of the membrane-located C6NBDPC
probe and its partitioning into the membrane are shown in
Fig. S1, A and B (see the Supporting Material), respectively,
as a function of P/L. The average lifetime of C6NBDPC
located in PC/PE/SM/CH SUVs increased with increasing
concentration of peptides, with G13L having by far the
biggest effect and G1E almost no effect. The increase of
C6NBDPC lifetime in the membrane upon addition of
peptide suggests either that
1. The peptide inhibited motions and increased packing
order in the neighborhood of the probe (the carboxyl
backbone region (34)),
2. The peptide caused C6NBDPC to partition deeper into
the membrane outer leaflet, or
3. The peptide prevented water from penetrating to the
neighborhood of the probe in the membrane outer leaflet.
Wild-type HA or gp41 fusion peptides do not result in
a change in the ratio of TMA-DPH lifetimes in water and
D2O buffers (8), nor do the HA mutants investigated here
(results not shown). This could mean that these peptides
do not alter water penetration into the bilayer interfacial
region or that they all induce deeper penetration of the probe
into the bilayer (33). Because the wild-type and mutant
peptides had very different effects on both C6NBDPC parti-
tioning (see Fig. S1 B) and TMA-DPH anisotropy, it indi-
cates that these have very different effects on free volume
and order within the upper regions of the bilayer. Thus,Biophysical Journal 101(5) 1095–1104
FIGURE 3 CD spectra of HA wild-type (solid line), G1E (dotted line),
and G13L (dashed line) in the presence of PC/PE/CH (2:1:1) SUVs. The
peptide concentration was 80 mM, and the lipid concentration was 2 mM.
Small amounts of peptide solution in dimethylsulfoxide were dried in
thin films on the surface of 3.5 mL brown vials. The films were frozen using
dry ice, and maintained overnight under high vacuum. Preformed SUVs (in
10 mM phosphate buffer at pH 5.0) were added to the vials and vortexed for
30 min to transfer to the membranes.
1100 Haque et al.we could not expect all three peptides to have the same
effect on positioning of TMA-DPH in the bilayer.
We conclude that none of the peptides at the P/Ls we
examined had a significant effect on water penetration into
the bilayer. Thus, decreased water penetration is not likely
the cause of the increased lifetime of C6NBDPC seen in
Fig. S1 A. Increased interfacial order and reduced thermal
motions likely plays a role in the increased C6NBDPC life-
time for G13L in Fig. S1 A, because it produced a dramatic
increase in TMA-DPH anisotropy (Fig. S2 A). The G1E
mutant has little perturbing effect on any region of the
bilayer (see Fig. S1 and Fig. S2). We conclude that only
the wild-type peptide significantly fills bilayer free volume
(see Fig. S1 B) and increases order in the bilayer interior
(see Fig. S2 B). The increased C6NBDPC lifetime that it
causes thus likely reflects this ability to fill space and
decrease thermal motion in the deeper regions of the bilayer.
Based on these observations, we conclude that
1. Wild-type HA peptide occupies available free volume,
increases order, and somewhat reduces thermal motion
in the membrane interior, while the mutant peptides do
not;
2. G13L occupies interfacial space more than wild-type or
G1E; and
3. G1E mutant had almost no effect on bilayer structure,
and certainly much less than either the wild-type or
G13L mutant peptides.FIGURE 4 PATIR-FTIR amide I0 spectra of HA wild-type (solid line),
G1E (dotted line), and G13L (dashed line) on a supported monolayer of
PC/PE/SM/CH. Parallel polarized (shown) and perpendicular polarized
spectra were collected for secondary structure and peptide orientation in
membrane at pH 5.0.Possible structures of the peptide-membrane
complexes
Wild-type peptide
The secondary structure of wild-type HA fusion peptide
and mutants were examined by both circular dichroism
(CD) and polarized attenuated total internal reflection
Fourier-transform infrared (PATIR-FTIR) spectroscopy.
Fig. 3 shows the CD spectra of all three peptides in PC/PE/
CH (2:1:1) vesicles. Analysis using CD Pro (http://lamar.
colostate.edu/~sreeram/CDPro/main.html) showed thewild-
type fusion peptide to be highly helical (~42%), with some
turn (~25%) and unordered structure (~33%) but no b-struc-
ture. Fig. 4 shows PATIR-FTIR amide I0 spectra of wild-type
andmutant peptides in PC/PE/SM/CHmonolayers supported
on a silanized germanium internal reflection crystal exposed
to bulk aqueous buffer at pH 5.0. Spectra were collected
with a polarizer oriented parallel (Fig. 4) and perpendicular
(not shown) to the plane of incidence, and these were
analyzed to obtain the dichroic ratios in Table S1 (see the
Supporting Material).
As previously reported (8), wild-type HA peptide ex-
hibited a split amide I0 band, with the bulk of the absorption
occurring in a broad band centered at 1649 cm1. This band
has a dichroic ratio of ~1.7, which is significantly less thanBiophysical Journal 101(5) 1095–1104the isotropic ratio for this system (Riso ¼ 2.34), indicating
a slight tendency for backbone peptide groups to be oriented
parallel to the membrane surface. The wild-type peptide
also has a prominent shoulder centered at 1625 cm1, a posi-
tion commonly associated with extended b secondary struc-
ture but possibly reflecting a more complex structure. It is
significant that this component has a dichroic ratio of 1.2,
close to the minimum possible ratio (Rmin ¼ 0.9), indicating
that a preponderance of the backbone peptide groups asso-
ciated with this secondary structure are very nearly parallel
to the membrane surface. Because this component is absent
in spectra taken with peptide associated with DOPC mono-
layers (8), the nature of this structural element depends on
the membrane with which it associates. There is no evidence
of b-structure in our CD spectrum of wild-type peptide, so it
seems unlikely that this secondary structure element is an
HA Fusion Peptide Mutants, PEG-Mediated Fusion 1101extended sheet. The NMR-based structure of wild-type
peptide reports a considerably disordered 3(10) helical
C-terminal structure, but also no b-structure (7).
Analysis of a 3(10) helical peptide shows a single weak
CD trough at ~208 nm (36), which we would have difficulty
resolving because significant a-helix is present. In addition,
the NMR structure was determined with a wild-type peptide
covalently linked to a solubilizing peptide and bound to
DPC micelles and thus may not contain the structural
elements present in the wild-type peptide bound to the
DOPC/DOPE/SM/CH vesicles used in this study. Taken
together, these results suggest that the C-terminus of HA
fusion peptide used in this study is a weakly ordered
H-bonded structure whose peptide units lie roughly parallel
to the bilayer. The fact that the wild-type peptide reduced
free volume and decreased thermal motions in the hydro-
phobic region of the bilayer, taken with the CD and FTIR
data, suggests that the largely hydrophobic N-terminal helix
of the wild-type peptide must protrude significantly into the
bilayer. This is consistent with our previously published
model (8) and with the model based on solution NMR of
the wild-type peptide joined to a soluble peptide carrier (7).
G13L peptide
The CD spectrum of the G13L peptide was less clearly
interpretable, although CD Pro (http://lamar.colostate.edu/
~sreeram/CDPro/main.html) analysis suggested that this
mutation increased unordered contributions at the expense
of helical content (~32%), leaving turn structure unchanged.
The G13L mutant also exhibited a split amide I0 band. While
the main peak and the shoulder were more narrowly split
than for wild-type HA, and thus more difficult to resolve,
the 1649 cm1 band was reduced relative to other bands,
consistent with the decrease in helical content suggested
by CD. The low frequency shoulder (1629 cm1) also had
a somewhat lower dichroic ratio (~1.5), consistent with
the behavior of the wild-type peptide—but again it is diffi-
cult to resolve bands this narrowly split, and resolution
enhancement techniques are not appropriate in this setting.
G13 is thought to be part of a motif that defines the
N-terminal helix of the wild-type peptide (18), so replacing
it with a leucine could break this helix and provide sufficient
hydrophobic driving force to draw the side chain at position
13 into the membrane and thus tilt the N-terminal helix
toward the bilayer interface, disrupting the inverted-V struc-
ture of the wild-type peptide. This would be consistent with
the G13L mutant increasing order at the bilayer interface
(see Fig. S2 A). This would also be consistent with this
peptide providing a somewhat less disordered environment
for C6NBDPC, explained in its increased lifetime (see
Fig. S1 A). This position should not increase interior order
(see Fig. S2 B) or decrease free volume (see Fig. S1 B), as
does wild-type peptide. Thus, our data suggest that the
G13L mutant has a shortened N-terminal helix that lies
near the membrane interface.G1E peptide
This peptide also yielded a poorly defined CD spectrum. CD
Pro (http://lamar.colostate.edu/~sreeram/CDPro/main.html)
analysis suggested appearance of b-sheet structure (~30%)
at the expense of turn and a-helix (24%). The G1E mutant
exhibited a broad featureless amide I0 absorption, with a
dichroic ratio of 1.6:1.8, again indicating a slight tendency
for backbone peptide groups to be oriented parallel to the
membrane surface but with a poorly defined secondary
structure or a variety of possible secondary structural
elements. Replacing the N-terminal glycine with a glutamic
acid should make it more difficult for the N-terminus of the
fusion peptide to insert into and fill space in the bilayer,
which is consistent with its lack of effect on interior mem-
brane order and free volume (see Fig. S1 and Fig. S2).
Moving the N-terminus toward the more polar interface
might also be expected to destabilize the N-terminal helix,
several residues of which are quite hydrophobic. If so, the
b-sheet component of the CD spectrum suggests that at least
some of the H-bonding potential of this helix might be satis-
fied through formation of some intermolecular b-sheet. A
location at or even slightly above the interface would be
consistent with the inability of this mutant to perturb the
bilayer (see Fig. S1 and Fig. S2).DISCUSSION
Our results are discussed below in the context of the kinetic
model summarized in Scheme 1 (17,33). In a calculation
based on lipid material properties and the modified or
extended stalk hypothesis (22), the initial (I1) and second
(I2) intermediates in SUV fusion are defined by minima
in the free energy of a hemifused vesicle pair as a function
of stalk radius (14). I1 corresponds to a slightly expanded
stalk and I2 to an expanded trans-membrane contact
(TMC) or diaphragm. This calculation predicts the TMC
structure to be a high-free-energy structure separating the
stalk and expanded TMC low free energy intermediates
(14). Vesicles brought into close contact by PEG (23)
constitute the initial aggregated state (A) from which fusion
proceeds in our experiments. The final fusion pore (FP)
state is envisioned as stable pores between juxtaposed vesi-
cles (17). Contents and lipids can mix between vesicles via
transitory events (i.e., flickering pores) that occur with finite
probability early in the fusion process before formation of
larger stable FPs (33). Thus, fusion peptides can promote
fusion by:
1. Altering the probabilities of contents mixing, a, and lipid
mixing, b, at each stage of the fusion process,
2. By affecting the rates of intermediate or fusion pore
formation, and
3. By influencing the total extent of content mixing (%CM)
or lipid mixing (%LM).Biophysical Journal 101(5) 1095–1104
1102 Haque et al.Each of these mechanisms can reflect different effects of the
peptide on lipid structures.
In this study, we determined the effects of wild-type HA
fusion peptide and its two mutants on
1. The binding with the membrane,
2. The different steps of PEG-induced model membrane
fusion, and
3. The structure of the PC/PE/SM/CH bilayers, and we also
obtained data related to the structure of the peptides on
the vesicles.
These studies were meant to answer three questions put
forth in the Introduction:
1. At what stage(s) of the fusion process does the wild-type
HA fusion peptide exert its fusion-promoting influence?
2. How does the wild-type peptide influence events at each
stage?
3. Can differences between the structures and influences on
bilayer structure of HA and wild-type mutant peptides
shed light on the mechanism(s) by which a wild-type
peptide promotes fusion?
Finally, these peptides influence lipid phase behavior (B. G.
Tenchov, D. P. Siegel, R. C. MacDonald, M. E. Haque, and
B. R. Lentz, unpublished, and B. R. Lentz, University of
North Carolina at Chapel Hill, personal communication,
2011), and we consider the potential importance of this
effect relative to other effects considered here. In answer
to the first two questions, the wild-type fusion peptide ex-
erted three major fusion-enhancing influences: a twofold
enhancement in the rate of initial intermediate formation
(k1) and a 30–50% increase in k2 and k3, promotion of
content mixing earlier in the fusion process (increased a1),
and a 40% increase in the extent of contents mixing or
fusion. In discussing these three effects, we also touch on
the other two questions raised here.
The k1 increase brought about by wild-type fusion peptide
reflects a decrease in the activation free energy for transition-
ing from the A to the I1 states. The transition state between A
and I1 is not semistable and cannot be described in terms of
material properties of lamellar or nonlamellar lipid phases,
as it must involve significant rearrangements of water and
lipid molecules in order to bridge the lamellar and nonlamel-
lar geometries of the A-state and the stalk intermediate (14).
Binding of wild-type HA fusion peptide must either raise the
free energy of the A-state or lower the free energy of the tran-
sition state. Because the SUVs used for these studies have
a positive curvature stress imposed on their exposed mono-
layer as well as a negative curvature stress associated with
their inner monolayer, this makes them prone to fusion
(37). It has been suggested that HA fusion peptide might
impart a negative curvature to lipid structures (10).
Of the three peptides examined, only thewild-type peptide
increased k1, filled free space in the exposed monolayer,
and increased lipid order in the bilayer (Table 1 and seeBiophysical Journal 101(5) 1095–1104Fig. S2 B). It also bound more avidly and in a way that occu-
pied more surface area. Binding of a peptide that does all this
should actually stabilize state A and inhibit fusion, as has
been reported for HA peptide and fusion of large unilamellar
vesicles having outer monolayers with induced positive
curvature stress (5). We conclude that the HA fusion peptide
likely stabilizes the transition state for formation of the
initial, hemifused fusion intermediate from the dehydrated
lamellar phase. However, we know nothing about the struc-
ture or thermodynamics of this transition state, so it is diffi-
cult to conclude more than that the wild-type peptide
stabilizes it and that the mutant peptides fail to do so.
Beyond increasing k1, wild-type fusion peptide also
increased k2 and k3. In the case of k2, fusion peptide could
influence either the free energy of the stalk or the free
energy of the barrier between the stalk and I2. This barrier
occurs just shy of the TMC structure as fusion intermediates
expand from the stalk through the TMC to the extended
TMC or diaphragm (see Fig. 3 of Malinin and Lentz
(14)). Because all these structures have the same topology
and thus Gaussian curvature, the major contributions to
the relative free energies of the stalk and diaphragm inter-
mediates arise from the increased (relative to the original
state of aggregated SUVs) interstice or void free energy
and the decreased bending free energy (14).
It has been suggested that HA fusion peptide might impart
a negative curvature to lipid structures (10), thereby stabi-
lizing fusion intermediates. Increasing the negative curva-
ture of each monolayer stabilizes both the stalk and the
TMC but increases the difference between their free energies
(14) and thus should decrease k2. Bothmonolayers contribute
to this effect, but increasing the negative curvature of only the
contiguous monolayer of fusion intermediates should stabi-
lize the stalk more than the TMC and thus decrease k2 even
more (14). Thus, it is unlikely that fusion peptide could
increase k2 by increasing the negative curvature of the contig-
uous monolayers. Bending free energy is the product of
bending modulus times the net of intrinsic and imposed
curvature stress (15), and the gp41 fusion peptide reduces
the bending modulus of lipid monolayers (12).
However, SUVs are so highly curved that they have a very
unfavorable bending free energy, and the structure that
exists between the stalk and the TMC has lower curvature
stress than either the stalk or the TMC and is disfavored
primarily by its interstice free energy (14). Thus, decreasing
the bending moduli of both contacting monolayers (12)
should diminish the effect of the negative intrinsic curvature
of our lipid mixture on both stalk and TMC by a constant
factor, and therefore diminish the free energy difference
between them by very little if at all. Thus, the interstice or
void or mismatch free energy probably constitutes the major
contribution to the free energy difference between stalk and
TMC, and this difference decreases as the mismatch volume
decreases (14). Neither the G13L nor G1E mutants altered
either the membrane free volume (see Fig. S1 B) or k2
HA Fusion Peptide Mutants, PEG-Mediated Fusion 1103(Table 1), while wild-type peptide both increased k2 and
decreased free volume. Thus, the wild-type HA fusion
peptide appears to increase k2 according to its ability to
occupy space and lower interstice free energy of the TMC
structure.
Just as for stalk formation (A to I1), pore formation (I2 to
FP) involves a change in topology and therefore must be
accomplished through some sort of an unstable disordered
transition state in which water and lipid molecules are in
contact. Thus, it is reasonable to presume that the wild-
type fusion peptide might stabilize such a transition state
as it does for the transition state leading to I1. However,
just as for I1 formation, we have too little information about
the transition state for final pore formation to understand
how the peptide accomplishes this. We note, however,
that the wild-type peptide increased the probability of
content mixing early in the fusion process (a1) and
increased the extent of content mixing (%CM) while the
G13L and G1E mutants had lesser, no, or opposite effects
(see Table 1).
The extent of content mixing reflects all the content
mixing events that occur by the time that content mixing
saturates. Content mixing occurs either when a stable fusion
pore forms, or when a porelike fluctuation in an intermediate
allows ANTS and DPX to pass between vesicles or to escape
to the external compartment (leakage). In either case, the
effect of the peptide must be to stabilize pore-like structures
relative to other structures comprising intermediates in the
fusion process. The stalk, TMC, and porelike structures
are proposed as intermediates between lamellar and either
hexagonal II or cubic phases (38). We show elsewhere
that HA fusion peptide promotes cubic phase over hexag-
onal and lamellar phase to a much greater extent than do
the G13L and G1E HA mutant peptides (B. G. Tenchov,
D. P. Siegel, R. C. MacDonald, M. E. Haque, and B. R.
Lentz, unpublished, and B. R. Lentz, University of North
Carolina at Chapel Hill, personal communication, 2011).
The origin of HA fusion peptide’s ability to promote cubic
phase is not established. It could be due to bending modulus
reduction (12), to induced negative intrinsic curvature (10),
to reduced interstice volume, or to a reduction in Gaussian
modulus. Despite this uncertainty, the experimental fact is
that wild-type HA fusion peptide might also promote
content mixing by stabilizing a final fusion pore or perhaps
by stabilizing porelike fluctuations in fusion intermediates
that could account for content mixing observed before
formation of a final fusion pore.
In summary, the effects ofHA fusion peptide on the kinetics
of content mixing (thus fusion) are likely attributed to:
1. Stabilization of transition states between the A and I1 or
the I2 and FP states;
2. Filling hydrophobic volume (thus lowering interstice
free energy) in the high free energy TMC structure and
increasing k2; and3. Stabilizing porelike fluctuations in fusion intermediates
or the final FP state, as suggested by its ability to promote
cubic phase formation (B. G. Tenchov, D. P. Siegel, R. C.
MacDonald, M. E. Haque, and B. R. Lentz, unpublished,
and B. R. Lentz, University of North Carolina at Chapel
Hill, personal communication, 2011).
In support of this proposal, the mutant peptides G1E and
G13L do not exhibit effects 1 or 2, and promote cubic phase
to a much smaller extent than does the wild-type peptide
(B. G. Tenchov, D. P. Siegel, R. C. MacDonald, M. E. Haque,
and B. R. Lentz, unpublished, and B. R. Lentz, University of
North Carolina at Chapel Hill, personal communication,
2011). Confirmation of the first effect will require further ex-
periments to establish the effects of fusion peptide on thermo-
dynamics of transition states between fusion intermediates.SUPPORTING MATERIAL
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